Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001045969-03-000685
Filing Date
2003-03-20
Accepted
2003-03-20 17:18:59
Documents
5
Period of Report
2002-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.txt 10-K 262197
3 CONSENT OF KPMG LLP dex23.txt EX-23 1039
4 CAUTIONARY STATEMENTS dex991.txt EX-99.1 39545
5 CERTIFICATION OF CHARLES N. BLITZER dex992.txt EX-99.2 1416
6 CERTIFICATION OF WILLIAM C. BROWN dex993.txt EX-99.3 1428
  Complete submission text file 0001045969-03-000685.txt   307738
Mailing Address 5775 WEST OLD SHAKOPEE RD SUITE 100 MINNEAPOLIS MN 55437
Business Address 5775 WEST OLD SHAKOPEE RD SUITE 100 BLOOMINGTON MN 55437 952-346-4700
MGI PHARMA INC (Filer) CIK: 0000702131 (see all company filings)

EIN.: 411364647 | State of Incorp.: MN | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-10736 | Film No.: 03611077
SIC: 2834 Pharmaceutical Preparations